scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1026423D |
P356 | DOI | 10.1371/JOURNAL.PONE.0126423 |
P932 | PMC publication ID | 4439119 |
P698 | PubMed publication ID | 25992776 |
P5875 | ResearchGate publication ID | 277084635 |
P50 | author | Dirk Lassner | Q51846321 |
Johannes Denk | Q59703132 | ||
Holger Jahn | Q43017711 | ||
Christine S Siegismund | Q45383056 | ||
P2093 | author name string | Sönke Arlt | |
Kai Boelmans | |||
P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
A novel pathway regulates memory and plasticity via SIRT1 and miR-134 | Q24624906 | ||
Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs | Q24635151 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The involvement of microRNAs in neurodegenerative diseases | Q26858788 | ||
MicroRNA profiling: approaches and considerations | Q26861675 | ||
Methodological challenges in utilizing miRNAs as circulating biomarkers | Q27027950 | ||
A blood based 12-miRNA signature of Alzheimer disease patients | Q27499741 | ||
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments | Q28236560 | ||
MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice | Q28287534 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
Alzheimer's disease | Q29616743 | ||
The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. | Q30539812 | ||
The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics | Q33249870 | ||
Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis | Q33498129 | ||
A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines | Q33538911 | ||
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. | Q33722837 | ||
Transcriptional landscape of the prenatal human brain | Q33926910 | ||
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease | Q34113001 | ||
miR-375 inhibits differentiation of neurites by lowering HuD levels | Q34119806 | ||
MicroRNA profiling: separating signal from noise | Q34135031 | ||
A new way of identifying biomarkers in biomedical basic-research studies | Q34273474 | ||
Proposed declassification of disease categories related to sexual orientation in the International Statistical Classification of Diseases and Related Health Problems (ICD-11) | Q34399598 | ||
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q34988061 | ||
Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers | Q35000824 | ||
Extracellular microRNA: a new source of biomarkers | Q35417685 | ||
Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease | Q35791628 | ||
microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF) | Q36499038 | ||
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease | Q36632979 | ||
An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells | Q36968407 | ||
The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. | Q37080125 | ||
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies | Q37158033 | ||
Epigenetics, oxidative stress, and Alzheimer disease | Q37169854 | ||
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases | Q37332243 | ||
Identification of differentially expressed microRNAs across the developing human brain | Q37341793 | ||
MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma | Q37669025 | ||
Epigenetic regulation in the pathophysiology of Alzheimer's disease | Q37680418 | ||
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians | Q37693146 | ||
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. | Q51889715 | ||
MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. | Q53457447 | ||
Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases. | Q54257764 | ||
Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. | Q37739709 | ||
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? | Q37778884 | ||
Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative | Q37952021 | ||
MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease | Q37961383 | ||
miR-9: a versatile regulator of neurogenesis | Q38169147 | ||
Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets | Q38194374 | ||
Robust microRNA stability in degraded RNA preparations from human tissue and cell samples | Q39717005 | ||
Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
Validation of a multiplex reverse transcription and pre-amplification method using TaqMan(®) MicroRNA assays. | Q42148804 | ||
A miRNA-tRNA mix-up: tRNA origin of proposed miRNA | Q43410236 | ||
Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease | Q43883164 | ||
MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. | Q44001848 | ||
Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease | Q44060098 | ||
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. | Q48208608 | ||
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus | Q48266570 | ||
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study | Q48296508 | ||
Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex | Q48637426 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
Alzheimer's disease | Q11081 | ||
biomarker | Q864574 | ||
microRNA profiling | Q112543306 | ||
P304 | page(s) | e0126423 | |
P577 | publication date | 2015-05-20 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease | |
P478 | volume | 10 |
Q92324148 | A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice |
Q39143773 | A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression. |
Q90574790 | A combined miRNA-piRNA signature to detect Alzheimer's disease |
Q38927615 | A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease |
Q39542328 | Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy |
Q64053941 | Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease |
Q38681920 | Alzheimer's Disease and ncRNAs. |
Q92670283 | An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease |
Q38887384 | An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases |
Q38855547 | Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? |
Q48343851 | Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity |
Q38979999 | Biomarkers for the Early Detection and Progression of Alzheimer's Disease |
Q89834995 | CD38 in Neurodegeneration and Neuroinflammation |
Q38599053 | CDC42 expression is altered by dioxin exposure and mediated by multilevel regulations via AhR in human neuroblastoma cells |
Q39293214 | CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study |
Q48140499 | Can Astrocytes Be a Target for Precision Medicine? |
Q90499162 | Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets |
Q34524908 | Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis |
Q58300998 | Circulating microRNAs disclose biology of normal cognitive function in healthy elderly people - a discovery twin study |
Q48066803 | Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know? |
Q90057646 | Diagnostic and prognostic value of microRNAs for Alzheimer's disease: a comprehensive meta-analysis |
Q47562648 | Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates. |
Q60300574 | Epigenetics of chronic inflammatory diseases |
Q47123147 | Exercise - induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects. |
Q64066945 | Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges |
Q33871862 | Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases. |
Q59510880 | Extracellular microRNAs as messengers in the central and peripheral nervous system |
Q92229339 | Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease |
Q59531635 | Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients |
Q41037766 | Identification of the Role of miR-142-5p in Alzheimer's Disease by Comparative Bioinformatics and Cellular Analysis |
Q42371042 | Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery |
Q60922781 | MiR-375 Has Contrasting Effects on Newcastle Disease Virus Growth Depending on the Target Gene |
Q47206473 | MicroRNA Exocytosis by Vesicle Fusion in Neuroendocrine Cells |
Q51758072 | MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease. |
Q38749271 | MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples |
Q42293337 | MicroRNA exocytosis by large dense-core vesicle fusion |
Q60305849 | MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study |
Q102213603 | MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies |
Q44618765 | MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy |
Q37106716 | MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1. |
Q36934113 | MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease |
Q90361808 | MicroRNA-219 alleviates glutamate-induced neurotoxicity in cultured hippocampal neurons by targeting calmodulin-dependent protein kinase II gamma |
Q36290224 | MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies. |
Q99711177 | MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers |
Q39215093 | MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease. |
Q38843644 | MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? |
Q26744819 | MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases |
Q41064717 | NeurimmiRs and Postoperative Delirium in Elderly Patients Undergoing Total Hip/Knee Replacement: A Pilot Study |
Q47880484 | Noncoding RNAs in neurodegeneration |
Q91629118 | Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans |
Q64103320 | Physical Activity Alleviates Cognitive Dysfunction of Alzheimer's Disease through Regulating the mTOR Signaling Pathway |
Q41099377 | Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease |
Q90975119 | Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease |
Q39079275 | Recent advances in molecular biomarkers for diabetes mellitus: a systematic review |
Q39010887 | Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting. |
Q42293425 | Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study |
Q64084849 | Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease |
Q48505093 | Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. |
Q55135975 | Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. |
Q41479449 | Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain |
Q41140915 | The Underexploited Role of Non-Coding RNAs in Lysosomal Storage Diseases. |
Q91973221 | The Western Diet Regulates Hippocampal Microvascular Gene Expression: An Integrated Genomic Analyses in Female Mice |
Q26774431 | Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies |
Q37640781 | Vincamine Alleviates Amyloid-β 25-35 Peptides-induced Cytotoxicity in PC12 Cells |
Q55414815 | miR-103 Promotes Neurite Outgrowth and Suppresses Cells Apoptosis by Targeting Prostaglandin-Endoperoxide Synthase 2 in Cellular Models of Alzheimer's Disease. |
Q89494070 | miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity |
Q39742529 | miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease |
Q39104808 | miRNAs as biomarkers of neurodegenerative disorders |
Search more.